Angiotensin I converting enzyme and the changes in our concepts through the years: Lewis K. Dahl memorial lecture

Hypertension

Volumn 16, Issue 4, 1990, Pages 363-370

  Erdös, Ervin G ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Angiotensin; Arginine carboxypeptidase; Bradykinin; Cloning, molecular; Enkephalins; Substance P

Indexed keywords

ANGIOTENSIN I; DIPEPTIDYL CARBOXYPEPTIDASE;

AMINO ACID SEQUENCE; ENZYME ACTIVITY; HUMAN; HYPERTENSION; MEDICAL RESEARCH; PEPTIDE ANALYSIS; PRIORITY JOURNAL; REVIEW; THEORETICAL STUDY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMAL; BASE SEQUENCE; HUMAN; MOLECULAR SEQUENCE DATA; PEPTIDYL-DIPEPTIDASE A; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025039169     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.16.4.363     Document Type: Review

References (62)

1. Lentz KE, Skeggs LT Jr, Woods KR, Kahn JR, Shumway NP: The amino acid composition of hypertensin II and its biochemical relationship to hypertensin I. J Exp Med 1956;104:183-191
2. Skeggs LT Jr, Kahn JR, Shumway NP: The preparation and function of the hypertensin-converting enzyme. J Exp Med 1956;103:295-299
3. Helmer OM: Differentiation between two forms of angiotonin by means of spirally cut strips of rabbit aorta. Am J Physiol 1957;188:571-577
4. Erdös EG, Sloane EM: An enzyme in human blood plasma that inactivates bradykinin and kallidins. Biochem Pharmacol. 1962;11:585-592
5. Erdös EG, Yang HYT: An enzyme in microsomal fraction of kidney that inactivates bradykinin. Life Sci 1967;6:569-574
6. Yang HYT, Erdös EG: Second kininase in human blood plasma. Nature 1967;215:1402-1403
7. Vane JR: The release and fate of vaso-active hormones in the circulation. Br J Pharmacol 1969;35:209-242
8. Ng KKF, Vane JR: Fate of angiotensin I in the circulation. Nature 1968;218:144-150
9. Ferreira SH: A bradykinin-potentiating factor (BPF) present in the venom of Bothrops jararaca. Br J Pharmacol 1965; 24:163-169
10. Werle E, Grunz M: Zur Kenntnis der darmkontrahierenden, uteruserregenden und blutdrucksenkenden Substanz DK. Biochem Z 1939;301:429-436
11. Erdös EG, Wohler JR: Inhibition in vivo of the enzymatic inactivation of bradykinin and kallidin. Biochem Pharmacol 1963;12:1193-1199
12. Bakhle YS: Conversion of angiotensin I to angiotensin II by cell-free extracts of dog lung. Nature 1968;220:919-921
13. Erdös EG: Converting enzyme and kininase II (letter to editor). Hypertension 1988;11:299
14. Cushman DW, Ondetti MA: Inhibitors of angiotensin-converting enzyme. Prog Med Chem 1980;17:42-104
15. Yang HYT, Erdös EG, Levin Y: Characterization of a dipeptide hydrolase (kininase II; angiotensin I converting enzyme) J Pharmacol Exp Ther 1971;177:291-300
16. Kato H, Suzuki T: Amino acid sequence of bradykinin-potentiating peptide isolated from the venom of Agkistrodon halys blomhoffii. Proc Jpn Acad 1970;46:176-181
17. Patchett AA, Cordes EH: The design and properties of N-carboxyalkyldipeptide inhibitors of angiotensin-converting enzyme Meister A, ed: Advances in Enzymology and Related Areas of Molecular Biology. 1985, vol 57 pp 1-84
18. Yang HYT, Erdös EG, Levin Y: A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim Biophys Acta 1970;214:374-376
19. Elisseeva YE, Orekhovich VN, Pavlikhina LV, Alexeenko LP: Carboxycathepsin - a key regulatory component of two physiological systems involved in regulation of blood pressure. Clin Chim Acta 1971;31:413-419
20. Erdös EG: Kininases, in Erdös EG, ed: Bradykinin, Kallidin and Kallikrein. Handbook of Experimental Pharmacology. Heidelberg, Springer-Verlag, supplement to vol XXV, 1979, pp 427-448
21. Johnson AR, Erdös EG: Metabolism of vasoactive peptides by human endothelial cells in culture: Angiotensin I converting enzyme (kininase II) and angiotensinase. J Clin Invest 1977; 59:684-695
22. Ryan JW, Day AR, Schultz DR, Ryan US, Chung A, Marlborough DI, Dorer FE: Localization of angiotensin converting enzyme (kininase II): I. Preparation of antibody-bemeoctapeptide conjugates. Tissue & Cell 1976;8:111-124
23. Bedrossian CWM, Woo J, Miller WC, Cannon DC: Decreased angiotensin-converting enzyme in the adult respiratory distress syndrome. Am J Clin Pathol 1978;70:244-247
24. Johnson AR, Coalson JJ, Ashton J, Larumbide M, Erdös EG: Neutral metalloendopeptidase in serum samples from patients with adult respiratory distress syndrome: Comparison with angiotensin-converting enzyme. Am Rev Resp Dis 1985; 132:1262-1267
25. Bönner G: Das Renale Kallikrein-Kinin-System. Heidelberg, Springer-Verlag, 1988, p 264
26. Gavras H: The place of angiotensin-converting enzyme inhibition in the treatment of cardiovascular diseases. N Engl J Med 1988;319:1541-1543
27. Gavras I, Gavras H: The use of ACE inhibitors in hypertension, in Kostis FB, DeFelice EA (eds): Angiotensin Converting Enzyme Inhibitors. Alan R Liss, Inc, 1987, pp 93-122
28. Carbonell LF, Carretero OA, Stewart JM, Scicli AG: Effect of a kinin antagonist on the acute antihypertensive activity of enalaprilat in severe hypertension. Hypertension 1988; 11:239-243
29. Scholkens BA, Linz W, Lindpaintner K, Ganten D: Angiotensin deteriorates but bradykinin improves cardiac function following ischaemia in isolated rat hearts. J. Hypertens 1987; 5(suppl 5):S7-S9
30. Erdös EG, Skidgel RA: Structure and functions of human angiotensin I converting enzyme (kininase II). Biochem Soc Transact 1985;13:42-44
31. Erdös EG, Skidgel RA: Human angiotensin I converting enzyme: Unusual substrate specificity and distribution. Hypertension 1986;8(suppl I):I-34-I-37
32. Ward PE, Gedney CD, Dowben RM, Erdös EG: Isolation of membrane-bound renal kallikrein and kininase. Biochem J 1975;151:755-758
33. Hall ER, Kato J, Erdös EG, Robinson CJG, Oshima G: Angiotensin I-converting enzyme in the nephron. Life Sci 1976;18:1299-1303
34. Schulz WW, Hagler HK, Buja LM, Erdös EG: Ultrastructural localization of angiotensin I converting enzyme (EC 3.4.15.1) and neutral metalloendopeptidase (EC 3.4.24.11) in the proximal tubule of the human kidney. Lab Invest 1988;59:789-797
35. Lantz I, Terenius L: High enkephalyl peptide degradation, due to angiotensin-converting enzyme-like activity in human CSF. FEBS Lett 1985;193:31-34
36. Skidgel RA, Defendini R, Erdös EG: Angiotensin I converting enzyme and its role in neuropeptide metabolism, in Turner AJ, ed: Neuropeptides and Their Peptidases. Chichester, England, Ellis-Horwood, 1987, pp 165-182
37. Erdös EG, Gafford JT: Human converting enzyme. Clin Exp Hypertens 1983;A5:1251-1262
38. Hooper NM, Keen J, Pappin DJC, Turner AJ: Pig kidney angiotensin converting enzyme. Purification and characterization of amphipathic and hydrophilic forms of the enzyme establishes C-terminal anchorage to the plasma membrane. Biochem J 1987;247:85-93
39. Igic R, Robinson CJG, Erdös EG: Angiotensin I converting enzyme activity in the choroid plexus and in the retina, in Buckley JP, Ferrario CM, eds: Central Actions of Angiotensin and Related Hormones. New York, Pergamon Press, 1977, pp 23-27
40. Erdös EG: Angiotensin I converting enzyme. Circ Res 1975; 36:247-255
41. Scicli AG, Carretero OA, Hampton A, Cortes P, Oza NB: Site of kininogenase secretion in the dog nephron. Am J Physiol 1976;230:533-536
42. Liu F-Y, Cogan MG: Angiotensin II stimulates early proximal bicarbonate absorption in the rat by decreasing cyclic adenosine monophosphate. J Clin Invest 1989;84:83-91
43. Ward PE, Sheridan MA, Hammon KJ, Erdös EG: Angiotensin I converting enzyme (kininase II) of the brush border of human and swine intestine. Biochem Pharmacol 1980; 29:1525-1529
44. Benuck M, Marks N: Co-identity of brain angiotensin converting enzyme with a membrane bound dipeptidyl carboxypeptidase inactivating Met-enkephalin. Biochem Biophys Res Commun 1979;88:215-221
45. Defendini R, Zimmerman EA, Weare JA, Alhenc-Gelas F, Erdös EG: Angiotensin-converting enzyme in epithelial and neuroepithelial cells. Newoendocrinol 1983;37:32-40
46. Yokosawa H, Fujii Y, Ishii S-i: Degradation of luteinizing hormone-releasing hormone by neuroblastoma cells and their membrane: Evidence for the involvement of a thiol protease and angiotensin-converting enzyme. J Neurochem 1987; 48:293-298
47. Orloff MS, Turner AJ, Bunnett NW: Catabolism of substance P and neurotensin in the rat stomach wall is susceptible to inhibitors of angiotensin converting enzyme. Reg Peptides 1986;14:21-31
48. 7 by inhibiting its degradation in mouse brain. Molec Pharmacol 1985;28:521-526
49. Shore SA, Stimler-Gerard NP, Coats SR, Drazen JM: Substance P-induced bronchoconstriction in the guinea pig. Enhancement by inhibitors of neutral metalloendopeptidase and angiotensin-converting enzyme. Am Rev Respir Dis 1988; 137:331-336
50. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G, Corvol P: Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA 1988;85:9386-939
51. Bernstein KE, Martin BM, Edwards AS, Bernstein EA: Mouse angiotensin-converting enzyme is a protein composed of two homologous domains. J Biol Chem 1989;264:11945-11951
52. 3H]RU 44 403: Role of chloride. Biochem Biophys Res Commun 1989; 163:718-725
53. Lattion A-L, Soubrier F, Allegrini J, Hubert C, Corvol P, Alhenc-Gelas F: The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme. FEBS Lett 1989;252:99-104
54. Kumar RS, Kusari J, Roy SN, Soffer RL, Sen GC: Structure of testicular angiotensin-converting enzyme. A segmental mosaic isozyme. J Biol Chem 1989;264:16754-16758
55. Cushman DW, Cheung HS, Sabo EF, Ondetti MA: Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochemistry 1977;16:5484-5491
56. Fhyrquist F, Hortling L, Grönhagen-Riska C: Induction of angiotensin I-converting enzyme by captopril in cultured human endothelial cells. J Clin Endocrinol Metab 1982; 55:783-786
57. Tan F, Weerasinghe DK, Skidgel RA, Tamei H, Kaul RK, Roninson I, Schilling JW, Erdös EG: The deduced protein sequence of the human carboxypeptidase N high molecular weight subunit reveals the presence of leucine-rich tandem repeats. J Biol Chem 1990;265:13-19
58. Ehlers MRW, Riordan JF: Angiotensin-converting enzyme: New concepts concerning its biological role. Biochemistry 1989;28:5311-5318
59. Drummer OH, Kourtis S, Johnson H: Formation of angiotensin II and other angiotensin peptides from Des-Leu 10-angiotensin I in rat lung and kidney. Biochem Pharmacol 1988;37:4327-4333
60. Changaris DG, Miller JJ, Levy RS: Angiotensin II geterated by a human renal carboxypeptidase. Biochem Biophys Res Commun 1986;138:573-579
61. Reilty CF, Tewksbury DA, Schechter NM, Travis J: Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J Biol Chem 1982;257:8619-8622
62. Wintroub BU, Schechter NB, Lazarus GS, Kaempfer CE, Schwartz LB: Angiotensin I conversion by human and rat chymotryptic proteinases. J Invest Dermatol 1984;83:336-339